Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by Weill Medical College of Cornell University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00194870
First received: September 12, 2005
Last updated: January 3, 2011
Last verified: January 2011
  Purpose

Patients with epilepsy undergoing deep brain stimulation (DBS) have electroencephalograms (EEGs) recorded before and during their stimulation treatment. Subsequently the investigators will be using computer-assisted analysis of the digitally-recorded EEG signals to assess the effects of DBS on the brain-wave frequency content and any abnormal seizure-like patterns that may be present.


Condition Intervention
Epilepsy
Procedure: computer-assisted analysis of the digitally-recorded EEG signals

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic

Resource links provided by NLM:


Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:
  • NA- observational study [ Time Frame: 5 years appr. ] [ Designated as safety issue: No ]

Estimated Enrollment: 10
Study Start Date: October 2003
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: A
NA - open label study
Procedure: computer-assisted analysis of the digitally-recorded EEG signals
computer-assisted analysis of the digitally-recorded EEG signals

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • To be scheduled to undergo deep brain stimulation therapy (DBS) in an attempt to treat intractable epilepsy

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00194870

Contacts
Contact: Douglas R Labar, MD, PhD 212-746-2359

Locations
United States, New York
Weill Medical College at Cornell University - Comprehensive Epilepsy Center Recruiting
New York, New York, United States, 10021
Contact: Bill Nikolov    212-746-2346      
Weill Cornell Medical College Recruiting
New York, New York, United States, 10065
Contact: Douglas Labar, MD, PhD    212-746-2359      
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Douglas R Labar, MD, PhD Weill Medical College at Cornell University
  More Information

No publications provided

Responsible Party: Douglas Labar, MD, PhD, Weill Cornell Medical College
ClinicalTrials.gov Identifier: NCT00194870     History of Changes
Other Study ID Numbers: 0309006367
Study First Received: September 12, 2005
Last Updated: January 3, 2011
Health Authority: United States: Food and Drug Administration

Keywords provided by Weill Medical College of Cornell University:
EEG
DBS

Additional relevant MeSH terms:
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on July 26, 2014